Ionis Pharma Stock Price (NASDAQ:IONS)

Add to My Stocks
$46.97 $0.27 (0.58%) IONS stock closing price Jan 20, 2017 (Closing)
Ionis Pharma
21 JAN 2017
amigobulls logo
IONS hand_up
IONS vs S&P 500
Closing Price: Jan 20, 2017
$46.97 ( 0.58%)
S&P 500
2271.3 ( 0.34%)
52 Week Price Range
1 Year Return: 3.3%
Q3 Growth*
Profitable ?
net image
2016 Q3 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

Ionis Pharma Snapshot Video

18 5 2

IONS Stock Details

Prev Close* : $46.70
Market Cap:
Day Low: $46.25
52 Week Low: $19.59
Open: $46.53
Volume: 1613962
Day High: $47.14
52 Week High: $57.00

Latest Stock Market News

Latest Articles

Ionis Pharma News - From Partners

IONS Stockcharts

View IONS PE ratio, PS ratio stocks charts and compare with peers.
IONS Chart
Note: Compare Ionis Pharma stock price history with the index and industry peers.

Ionis Pharma Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Ionis Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

IONS Industry Peers

Company Price Change (%)
Recordati Indus (RCDTF)31.350 (0%)
United Therapeutics (UTHR)152.60.84 (0.55%)
Alnylam Pharma (ALNY)38.960.12 (0.31%)
Roche Holdings (RHHBY)29.190.23 (0.79%)
Biogen Inc (BIIB)280.660.31 (0.11%)
Johnson & Johnson (JNJ)114.150.05 (0.04%)
Achaogen (AKAO)17.551.29 (6.85%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Aralez Pharma (ARLZ)4.40.34 (8.37%)
Concert Pharma (CNCE)9.370.52 (5.88%)
AVADEL PHARMA (AVDL)10.310.4 (4.04%)
Nutraceutical International (NUTR)34.80.4 (1.16%)
Aratana Therapeutics (PETX)7.620.08 (1.06%)
La Jolla Pharma (LJPC)20.130.2 (1%)
Zoetis (ZTS)53.970.47 (0.88%)
Top gainers from Medical-Drugs industry
* As of Jan 21, 2017
CompanyPriceChange (%)
Synergy Pharma (SGYP)5.910.5 (7.8%)
Achaogen (AKAO)17.551.29 (6.85%)
Cempra (CEMP)30.2 (6.25%)
Xencor (XNCR)21.741.01 (4.44%)
Endo International (ENDP)12.340.56 (4.34%)
Egalet (EGLT)5.020.22 (4.2%)
Durect (DRRX)1.180.05 (4.07%)
Top losers from Medical-Drugs industry
* As of Jan 21, 2017

Ionis Pharma Financial Statements

income statement20152014201320122011
Net Sales Or Revenues283.7M214.16M147.28M102.04M99.08M
Net Income-88.27M-38.98M-60.64M-65.47M-84.8M
Total Operating Expense359.46M261.89M198.94M170.96M170.17M
view Ionis Pharmaceuticals Inc income statement
balance sheet20152014201320122011
Total Assets956.1M955.8M847.15M545.68M484.89M
Total Liabilities755.31M698.02M468.76M362.92M313.46M
Shareholders Equity200.79M257.78M378.39M182.76M171.43M
view Ionis Pharmaceuticals Inc balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) In Assets Liabilities20.57M5.21M86.02M50.2M-67.39M
Net Cash From (Used By) Operating Activities21.12M6.28M63.49M1.87M-114.8M
Increase (Decrease) In Prop Plant And Equipment-7.69M-7.51M-1.55M-1.47M-7.33M
view Ionis Pharmaceuticals Inc cashflow statement

Ionis Pharmaceuticals Inc Stock News - Partner Headlines

Ionis Pharma Stock Message Board

As of last trading day, Ionis Pharma stock price was 46.97. Ionis Pharma market capitalization is 5.66B and it represents the total market value of IONS stock. A value investor must look at the fundamentals of a stock, and perform Ionis Pharma valuation, even though in the short-term sentiment and current breaking news might affect Ionis Pharma stock price.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Ionis Pharma is worth a lot, it will most likely be reflected in an inflated Ionis Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 1613962 shares were traded with a closing stock price of 46.97 as of 20 Jan, 2017, as can be seen from Ionis Pharma stock quote. One can view Ionis Pharma stock chart to follow the stock price trend. A dividend is a cash payment from a company's earnings and is distributed among shareholders. Ionis Pharma does not pay dividends. One can observe stock price trends and check for volatility by checking Ionis Pharma stock price history.